Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Octanoic Acid in Essential Tremor
NCT00848172Phase 2Completed
- Sponsor
- National Institute of Neurological Disorders and Stroke
- Start
- Feb 2009
- Primary completion
- Nov 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of Octanoic acid in essential tremor (ET), sponsored by National Institute of Neurological Disorders and Stroke. Started Feb 2009; status: completed.
02
Drugs
Octanoic acid
03
Conditions
essential tremor (ET)
Beyond the preview
Go deeper on NCT00848172.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00848172.